Table 1.
Descriptive Statistics
| Variable | All Participants | CD38 A Allele Carriers | CD38 C/C Homozygotes |
|---|---|---|---|
|
Gender
| |||
| Female | 279 (69.8%) | 112 (68.7%) | 167 (70.5%) |
| Male | 121 (30.3%) | 51 (31.3%) | 70 (29.5%) |
| Race and ethnicity | |||
| Caucasian | 193 (48.0 %) | 94 (57.7%) | 99 (41.8%) |
| Black | 54 (13.5%) | 6 (3.7%) | 48 (20.3%) |
| Hispanic / Latino | 58 (14.7%) | 24 (14.7%) | 34 (14.3%) |
| Other | 95 (23.8%) | 39 (23.9%) | 56 (23.6%) |
| Screener risk level | |||
| Highest tertile | 232 (58.0%) | 96 (58.9%) | 136 (57.4%) |
| Middle tertile | 97 (24.3%) | 39 (23.9%) | 58 (24.5%) |
| Lowest tertile | 71 (17.8%) | 28 (17.2%) | 43 (18.1%) |
| CD38 genotype | |||
| AA | 53 (13.3%) | - | 53 (22.4%) |
| AC | 184 (44.9%) | - | 184 (77.6%) |
| CC | 163 (39.8%) | 163 (100%) | - |
| Age in years at baseline | 16.12 (0.43) | 16.12 (.41) | 16.11 (.45) |
| Baseline EPQ-R Neuroticism score | 11.88 (4.48) | 11.98 (4.49) | 11.81 (4.48) |
| Hollingshead SES Score | 48.47 (12.58) | 49.70 (13.03) | 47.63 (12.22) |
| Annual SCID Interviews completed | 5.31 (.97) | 5.33 (.97) | 5.29 (.97) |
| Self-reported social anxiety symptom items completed | 4.59 (1.27) | 4.65 (1.30) | 4.54 (1.26) |
| Self-reported depression symptom items completed | 4.71 (1.23) | 4.79 (1.23) | 4.65 (1.22) |